← Back

Shandong Wohua Pharmaceutical Co Ltd

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu tablets, Hedan tablets and capsules, Naoxueshu and Shenzhiling oral liquid, and Tongluo Huatan capsules; and drugs for musculoskeletal disorders, including Gusukang capsules/granules and Yidu Hanbi liquid; Yidu cold-rheumatism medicinal wine ingredients; brain blood circulation oral solution; Amber stone granules for urinary system diseases; Children's antipyretic granules for pediatric medication; Anti-itching granules for skin diseases; and Bile grass capsule for digestive and gynecological diseases, as well as Silkworm Nourishing Blood and Benefiting Kidney Granules for gynecological medication. In addition, the company offers Amber Xiaoshi granules, and Siyu Yangxue Yishen granules; Yanreqing granules, Antiviral oral liquid, and Niuhuang Yijin tablets for the treatment of dry throat and sore throat; Yinhuang granules for the treatment of wind-heat colds; Tongxuan Lifei pills for the treatment of wind-cold colds; Fangfeng Tongsheng pills for colds on the surface and heat inside; Huoxiang Zhengqi Water for the treatment of summer-heat colds; Shenling Baizhu, Buzhong Yiqi, and Xiangsha Liujun pills for the treatment of physical weakness colds; and Juhong Li Gao for the treatment of dry coughs with little sputum. The company was founded in 2003 and is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. operates as a subsidiary of Beijing Zhongzheng Wanrong Investment(Group) Co., Ltd.

Price · split & dividend adjusted
News & notes moving 002107.CS
002107.CS

複数のA株企業が半期配当を集中発表、行動教育は10株当たり12元を計画

8月11日夜、複数のA株上場企業が2026年半期の配当実施案または予定案を集中発表した。このうち行動教育は10株当たり現金配当12元(税込み)を計画し、総額1億4300万元の配当を見込む。新天然気は10株当たり現金配当8元(税込み)を計画し、総額3億3900万元の配当を見込む。江河集団は1株当たり現金配当0.25元(税込み)を計画し、総額2億8300万元の配当を見込む。海康威視は権利落ち配当実施公告を発表し、全株主に対し10株当たり現金配当5.50元(税込み)を実施、累計配当総額は50億4100万元に達し、権利確定日は8月18日となる。このほか、甬金股份、沃華医薬、湖北宜化、長城科技、東百集団、富祥股份なども配当計画を開示した。
证券时报·15d続きを読む ▾
002107.CS2

沃華医薬、2026年中間決算で純利益が前年同期比51.23%増

沃華医薬が発表した2026年中間決算によると、親会社株主に帰属する純利益は6756万6300元で、前年同期比51.23%増となり、2年連続の増益を達成した。営業総収入は3億9300万元で、前年同期比7.53%減。営業活動によるキャッシュフローは8136万7500元の純流入で、前年同期比8.07%増。最新の負債比率は26.32%、粗利益率は77.84%、ROEは9.56%、希薄化後1株当たり利益は0.12元。
Jiemian·42d続きを読む ▾